FDA approves Amgen’s anti-osteoporosis drug, Prolia
- June 02, 2010
Federal regulators approved Amgen Inc.’s anti-osteoporosis drug, Prolia, on Tuesday for use by postmenopausal women who face a high risk of bone fractures. One of every two women over the age ... Read More